NEW DRUG TARGET IDENTIFIED (Acne) FOR FIGHTING PARKINSON'S DISEASE

NEW DRUG TARGET IDENTIFIED FOR FIGHTING PARKINSON'S DISEASE
Researchers at Johns Hopkins' Institute for Cell Engineering (ICE) have discovered a protein that could be the best new target in the fight against Parkinson's disease since the brain damaging condition was first tied to loss of the brain chemical dopamine.

FDA Strengthens Safety Warning on Aprotinin Label
The FDA has strengthened the label safety warning for the antifibrinolytic drug aprotinin, emphasizing the importance of limiting use of the agent to patients undergoing CABG.Medscape Medical NewsShelley Wood

Premium Health Search Engine